Veronique Vallet
Overview
Explore the profile of Veronique Vallet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
377
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sahin A, Romano E, Casutt A, Moeckli R, Vallet V, El Chammah S, et al.
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941736
Background/objectives: Stereotactic body radiation therapy (SBRT) has demonstrated high local control rates for inoperable early-stage lung cancers. However, 5-15% of patients experience local relapse within the irradiated volume after treatment,...
2.
Gondre M, Vallet V, Bourhis J, Bochud F, Moeckli R
J Appl Clin Med Phys
. 2024 Dec;
26(3):e14585.
PMID: 39698880
Purpose: Treatment planning for CyberKnife (CK) (Accuray, USA) can be performed with Precision (Accuray, USA) or RayStation (RS) (RaySearch Laboratories, Sweden) treatment planning systems (TPS). RaySearch recently released a new...
3.
Trojani V, Grehn M, Botti A, Balgobind B, Savini A, Boda-Heggemann J, et al.
Int J Radiat Oncol Biol Phys
. 2024 Aug;
121(1):218-229.
PMID: 39122095
Purpose: STereotactic Arrhythmia Radioablation (STAR) showed promising results in patients with refractory ventricular tachycardia. However, clinical data are scarce and heterogeneous. The STOPSTORM.eu consortium was established to investigate and harmonize...
4.
Cloitre M, Benkhaled S, Boughdad S, Schaefer N, Prior J, Zeverino M, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893216
We investigated spatial patterns between primary and recurrent tumor sites and assessed long-term toxicity after dose escalation stereotactic body radiation therapy (SBRT) to the dominant intra-prostatic nodule (DIN). In 33...
5.
Kinj R, Hottinger A, Bohlen T, Ozsahin M, Vallet V, Dunet V, et al.
Cancers (Basel)
. 2024 May;
16(9).
PMID: 38730695
Purpose: to evaluate an SRT approach in patients with at least 10 lesions at the time of BM initial diagnosis. Methods: This is a monocentric prospective cohort of patients treated...
6.
Le Reun E, Granzotto A, Petre A, Bodgi L, Beldjoudi G, Lacornerie T, et al.
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568795
Stereotactic body radiation therapy (SBRT) has made the hypofractionation of high doses delivered in a few sessions more acceptable. While the benefits of hypofractionated SBRT have been attributed to additional...
7.
Bohlen T, Germond J, Traneus E, Vallet V, Desorgher L, Ozsahin E, et al.
Med Phys
. 2023 Jul;
50(9):5745-5756.
PMID: 37427669
Background: Pre-clinical ultra-high dose rate (UHDR) electron irradiations on time scales of 100 ms have demonstrated a remarkable sparing of brain and lung tissues while retaining tumor efficacy when compared...
8.
Cloitre M, Valerio M, Mampuya A, Rakauskas A, Berthold D, Tawadros T, et al.
Br J Radiol
. 2023 Feb;
96(1145):20220803.
PMID: 36745031
Objectives: We conducted a phase I/II prospective trial to determine whether stereotactic dose escalation to the dominant intra-prostatic nodule (DIN) up to 50 Gy incorporating a rectal balloon spacer is...
9.
Gondre M, Conrad M, Vallet V, Bourhis J, Bochud F, Moeckli R
J Appl Clin Med Phys
. 2022 Jul;
23(8):e13732.
PMID: 35856911
Background: RaySearch (AB, Stockholm) has released a module for CyberKnife (CK) planning within its RayStation (RS) treatment planning system (TPS). Purpose: To create and validate beam models of fixed, Iris,...
10.
Muggeo-Bertin E, Moeckli R, Vallet V, Berthold D, Godin S, Bourhis J, et al.
Tech Innov Patient Support Radiat Oncol
. 2021 Jun;
19:7-10.
PMID: 34189285
This article describes a ureter-sparing procedure used to treat lymph node metastases with SBRT. We delivered 35 Gy in 5 fractions of 7 Gy to patients with lesions located less...